GT Biopharma
GTBP
GTBP
53 hedge funds and large institutions have $32.1M invested in GT Biopharma in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% less call options, than puts
Call options by funds: $553K | Put options by funds: $925K
54% less capital invested
Capital invested by funds: $69.7M → $32.1M (-$37.6M)
Holders
53
Holding in Top 10
–
Calls
$553K
Puts
$925K
Top Buyers
| 1 | +$1.47M | |
| 2 | +$1.1M | |
| 3 | +$729K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$636K |
| 5 |
Renaissance Technologies
New York
|
+$571K |
Top Sellers
| 1 | -$3.33M | |
| 2 | -$1.74M | |
| 3 | -$544K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$394K |
| 5 |
CCM
Conway Capital Management
Burbank,
California
|
-$318K |